Pfizer Stock Price Prediction

<div class='circular--portrait' style='background:#FF0F00;color: #FFFFF0;font-size:3em;padding-top: 38px;;'>PFE</div>
PFE -- USA Stock  


Pfizer Inc stock price prediction is an act of determining the future value of Pfizer shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Pfizer stock future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Pfizer Inc, which may create opportunities for some arbitrage if properly timed. Please check Pfizer Basic Forecasting Models to cross-verify your projections.

Search Stock Price Prediction

The Pfizer stock price prediction module also provides an analysis of price elasticity to changes in media outlook on Pfizer over a specific investment horizon. Using Pfizer hype-based prediction, you can estimate the value of Pfizer Inc from the perspective of Pfizer response to recently generated media hype and the effects of current headlines on its competitors. Pfizer Calculated Tax Rate is expected to significantly decrease based on the last few years of reporting. The last year's Calculated Tax Rate was at 7.83. The current year Inventory Turnover is expected to grow to 1.59, whereas PPandE Turnover is expected to decline to 3.59.
Estimates (3)
LowProjected EPSHigh
LowEstimated ValueHigh
LowReal ValueHigh
LowNext ValueHigh
Consensus (9)
LowTarget PriceHigh

Pfizer After-Hype Price Density Analysis

 Next price density 
      Expected price to next headline 

Pfizer Estimiated After-Hype Price Volatility

Current Value
5th of June 2020
After-hype Price
Pfizer is very steady asset. Analysis and calculation of next after-hype price of Pfizer Inc is based on 3 months time horizon.

Pfizer Stock Price Prediction Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.16  3.27  0.04   0.54  8 Events / Month3 Events / MonthIn about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Pfizer Hype Timeline

On the 5th of June Pfizer Inc is traded for 36.01. The entity has historical hype elasticity of -0.04 and average elasticity to hype of competition of -0.54. Pfizer Inc is estimated to decline in value after the next headline with price expected to drop to 35.98. The average volatility of media hype impact on the company stock price is about 1211.11%. The price depreciation on the next news is expected to be -0.08% where as daily expected return is at this time at 0.16%. The volatility of related hype on Pfizer is about 96.8% with expected price after next announcement by competition of 35.47. About 73.0% of the company shares are owned by institutional investors. The book value of Pfizer was at this time reported as 10.64. The company last dividend was issued on 2020-05-07. Pfizer Inc had 3:1 split on 1999-07-01. Considering 30-days investment horizon, the next estimated press release will be in about 8 days.
Please check Pfizer Basic Forecasting Models to cross-verify your projections.

Pfizer Related Hype Analysis

At Risk
Vertex Pharmaceuticals Incorpor(10.86) 11 per month 3.81  0.06  7.47 (6.48)  22.03 
Allergan Plc 0.00 0 per month 0.00 (0.06)  2.16 (2.24)  15.73 
Pfizer Inc(0.27) 8 per month 3.12  0.0071  6.12 (6.68)  16.70 
Dr Reddys Laboratories 0.11 8 per month 2.71  0.10  4.77 (5.71)  11.77 
Sinovac Biotech 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Zoetis Inc(0.32) 10 per month 4.53  0.0053  4.65 (7.67)  19.34 
Immune Pharmaceuticals 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Perrigo Company Plc(0.72) 7 per month 3.66  0.0066  6.96 (6.95)  22.87 
PAREXEL International Corp 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Regeneron Pharmaceuticals(21.72) 10 per month 3.42  0.09  6.92 (5.31)  22.03 

Additional Predictive Modules

About Pfizer Predictive Indicators

The successful prediction of Pfizer stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Pfizer Inc, already reflect all publically available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'text-book' version of this hypothesis and continually tries to find mispriced stocks to increase returns on his or her portfolios. We use internally-developed statistical techniques to arrive at the intrinsic value of BlackBerry Limited based on analysis of Pfizer hews, social hype, and general headline patterns together with widely used predictive technical indicators. We also calculate exposure to Pfizer's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Pfizer's related companies.
 2017 2018 2019 2020 (projected)
Long Term Debt to Equity0.4703260.5190.56940.494106
Interest Coverage14.6111.787.679.09
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer operates under Drug ManufacturersGeneral classification in USA and is traded on BATS Exchange. It employs 88300 people.
Please check Pfizer Basic Forecasting Models to cross-verify your projections. Please also try ETF Directory module to find actively-traded exchange traded funds (etf) from around the world.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page